| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850278 | American Heart Journal | 2011 | 10 Pages |
Abstract
Over the last decade, NSTE-ACS patients with diabetes continue to be treated more conservatively, despite evidence that they would derive similar or even greater benefits from aggressive treatment. This underutilization of evidence-based therapies among diabetic patients with NSTE-ACS in the “real world” may partly explain their worse outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Basem MD, Nabeel MD, Raymond T. MD, Keith A.A. MB, ChB, FRCP, Kim A. MD, Carolyn MD, J. Paul MD, Richard MD, Krishnan MD, Yves MD, Lawrence A. MD, Shaun G. MD, MSc, Andrew T. MD,